These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30663743)

  • 1. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds.
    Singh A; Lumb I; Mehra V; Kumar V
    Dalton Trans; 2019 Feb; 48(9):2840-2860. PubMed ID: 30663743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?
    Sharma B; Kumar V
    J Med Chem; 2021 Dec; 64(23):16865-16921. PubMed ID: 34792350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.
    Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
    Li L; Ma L; Sun J
    Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
    Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
    Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in Vitro Antiplasmodial and Antiproliferative Activity of New Ferrocene-Based α-Aminocresols Targeting Hemozoin Inhibition and DNA Interaction.
    Mbaba M; Dingle LMK; Swart T; Cash D; Laming D; de la Mare JA; Taylor D; Hoppe HC; Biot C; Edkins AL; Khanye SD
    Chembiochem; 2020 Sep; 21(18):2643-2658. PubMed ID: 32307798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
    Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
    Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current scenario of ferrocene-containing hybrids for antimalarial activity.
    Xiao J; Sun Z; Kong F; Gao F
    Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cells.
    Cázares-Marinero Jde J; Top S; Vessières A; Jaouen G
    Dalton Trans; 2014 Jan; 43(2):817-30. PubMed ID: 24153445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formylation of a metathesis-derived
    Mazur M; Mrozowicz M; Buchowicz W; Koszytkowska-Stawińska M; Kamiński R; Ochal Z; Wińska P; Bretner M
    Dalton Trans; 2020 Aug; 49(33):11504-11511. PubMed ID: 32627790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
    Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
    Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, docking, machine learning and antiproliferative activity of the 6-ferrocene/heterocycle-2-aminopyrimidine and 5-ferrocene-1H-Pyrazole derivatives obtained by microwave-assisted Atwal reaction as potential anticancer agents.
    Filho EV; Pina JWS; Antoniazi MK; Loureiro LB; Ribeiro MA; Pinheiro CB; Guimarães CJ; de Oliveira FCE; Pessoa C; Taranto AG; Greco SJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128240. PubMed ID: 34217828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.
    Bárány P; Oláh RS; Kovács I; Czuczi T; Szabó CL; Takács A; Lajkó E; Láng O; Kőhidai L; Schlosser G; Bősze S; Mező G; Hudecz F; Csámpai A
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue.
    Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR
    Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
    Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
    Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferrocifen type anti cancer drugs.
    Jaouen G; Vessières A; Top S
    Chem Soc Rev; 2015 Dec; 44(24):8802-17. PubMed ID: 26486993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
    Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
    Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.